Chips&Media, Inc., based in Seoul, Korea, is a global leader in silicon Hardware IP technology and delivers a wide range of multimedia IPs including video codecs and application-specific NPU IPs. We have launched an image quality-enhancing NPU, the Chips&Media Neural Processor (CMNP). Our products combine high performance with minimal power consumption, low bandwidth, and an optimized gate size while remaining cost-effective. Chips&Media boasts strong industry expertise and international cooperation with foundries and design houses. For more information, please visit us our website at https://www.chipsnmedia.com/
CHEMLAND Co., Ltd.
We would be delighted to introduce our outstanding materials. “We Make a Beautiful Life.” Founded in 1999, CHEMLAND, based in Korea, is a leading manufacturer of functional cosmetic ingredients, committed to delivering customer satisfaction through advanced technology and consistent high-quality standards. We specialize in surface-treated powders, CC Beads, Bead Shape Powder(Silica, SESQ), HALAL-certified modeling masks, and active ingredients, offering innovative solutions for a wide range of cosmetic applications. Through strong technical expertise and strategic partnerships, we continuously develop unique surface treatment technologies and high-performance materials tailored to global market needs. Discover technology beyond technology.
Charmcare Co., Ltd.
CHARMCARE is a Korean manufacturing company that develops the Wearable Blood Pressure Monitor which can be used Anytime & Anywhere. The Easiest Healthcare Monitoring in the World. H2-BP and H2-ABPM!
CHAEVI
CHAEVI manufactures, installs and operates a variety of chargers from 7kW slow chargers, 50kW, 100kW, 200kW fast chargers, and 400kW Ultra- fast chargers. ‘One-stop total solution’ from operation (CPO), payment service, and mobility charging MSP business to provide customer-oriented charging services.
CHA Vaccine Institute
CHA Vaccine Institute (KOSDAQ: 261780) – Pioneering Next-Generation Vaccines & Immunotherapies CHA Vaccine Institute is a cutting-edge biotechnology company dedicated to developing transformative therapeutic and prophylactic vaccines, as well as innovative cancer immunotherapies. Proprietary Adjuvant Platforms: Our TLR2/TLR3 agonist combination significantly enhances vaccine efficacy and anti-cancer immune responses. Addressing Critical Medical Needs: Targeting high-value markets, including Chronic Hepatitis B ($5.6B) and Herpes Zoster ($5.0B). Robust Clinical Pipeline: Advancing three clinical trials, including a Phase 2b vaccine and two Phase 1 prophylactic vaccines. Strong Intellectual Property Portfolio: Protecting innovation with 40 global patents. Expert Leadership: Led by a team of seasoned biotech professionals driving innovation and growth.
CGPIXEL STUDIO INC
CGPIXEL STUDIO’s “Hybrid Virtual Human System-Based AI Content Platform” addresses AI’s copyright risks, significantly reduces costs and production time, and reduces reliance on professionals to reduce barriers to entry across the industry, and helps create new opportunities in the global AI content market.